
MorphoSys AG MOR
Annual report 2023
added 12-27-2025
MorphoSys AG ROA Ratio 2011-2026 | MOR
Annual ROA Ratio MorphoSys AG
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -20.13 | 5.9 | -20.75 | -10.43 | -16.81 | - | - | - | - | - | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.9 | -20.75 | -12.44 |
ROA Ratio of other stocks in the Biotechnology industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
-241.53 | - | 5743.5 % | $ 69.7 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-22.19 | - | 1.35 % | $ 17.8 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
6.02 | $ 16.81 | -2.83 % | $ 786 M | ||
|
AgeX Therapeutics
AGE
|
-275.96 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
7.43 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
3.33 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-89.6 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
23.87 | - | 2.54 % | $ 160 B | ||
|
AstraZeneca PLC
AZN
|
8.97 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-53.39 | - | -1.52 % | $ 24.7 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
-24.26 | $ 7.58 | -3.19 % | $ 208 M | ||
|
Athira Pharma
ATHA
|
-114.6 | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
-40.14 | - | 0.74 % | $ 768 M | ||
|
Galera Therapeutics
GRTX
|
2071.28 | - | -32.59 % | $ 7.61 M | ||
|
Midatech Pharma plc
MTP
|
-35.12 | - | -18.52 % | $ 27.3 M | ||
|
AbCellera Biologics
ABCL
|
-10.79 | $ 4.08 | -7.39 % | $ 1.22 B | ||
|
Autolus Therapeutics plc
AUTL
|
-48.81 | $ 1.61 | 1.26 % | $ 428 M | ||
|
Compugen Ltd.
CGEN
|
22.57 | $ 2.77 | -8.75 % | $ 259 M | ||
|
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - | ||
|
BioNTech SE
BNTX
|
-5.17 | $ 89.59 | -2.61 % | $ 21.7 B | ||
|
Coherus BioSciences
CHRS
|
65.04 | $ 1.6 | -2.15 % | $ 187 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
-77.89 | - | - | $ 231 M | ||
|
Advaxis
ADXS
|
-289.96 | - | -9.65 % | $ 45.9 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-103.3 | $ 3.43 | -3.65 % | $ 5.65 M | ||
|
Aeterna Zentaris
AEZS
|
-48.33 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-19.95 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-35.55 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-27.57 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-19.87 | - | 1.93 % | $ 17.4 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
53.1 | $ 0.72 | -2.32 % | $ 32.9 M | ||
|
Esperion Therapeutics
ESPR
|
-4.87 | $ 3.13 | 0.16 % | $ 651 M | ||
|
Akero Therapeutics
AKRO
|
-30.52 | - | - | $ 3.67 B | ||
|
Eton Pharmaceuticals
ETON
|
-4.99 | $ 30.12 | -1.94 % | $ 810 M | ||
|
Aptose Biosciences
APTO
|
-254.37 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-97.25 | - | -39.0 % | $ 4.57 M | ||
|
Akouos
AKUS
|
-31.09 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-11.27 | - | -0.23 % | $ 916 M | ||
|
Exelixis
EXEL
|
27.51 | $ 50.55 | -1.08 % | $ 13.7 B | ||
|
AlloVir
ALVR
|
-35.68 | - | 4.14 % | $ 49.1 M | ||
|
Allakos
ALLK
|
-76.23 | - | - | $ 28.6 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-3.73 | $ 21.54 | -0.16 % | $ 2.74 B | ||
|
Allena Pharmaceuticals
ALNA
|
-140.01 | - | 3.16 % | $ 1.9 M | ||
|
Fortress Biotech
FBIO
|
19.94 | $ 2.39 | 3.91 % | $ 66.7 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-150.49 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
-117.57 | - | - | $ 10.1 M | ||
|
Alpine Immune Sciences
ALPN
|
-20.15 | - | - | $ 2.17 B | ||
|
Forte Biosciences
FBRX
|
-83.81 | $ 23.52 | -1.86 % | $ 305 M | ||
|
Fennec Pharmaceuticals
FENC
|
-13807.03 | $ 10.11 | 9.36 % | $ 289 M | ||
|
Aileron Therapeutics
ALRN
|
-206.44 | - | 10.36 % | $ 9.8 M |